Clinical Trial Update: The CYPHER™ Stent Study in Patients With Small de Novo Coronary Artery Lesions. [Phase 4]

View source ↗

Summary

Phase 4 trial update showing the CYPHER Stent study in patients with small de novo coronary artery lesions has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Cypher Stent (sirolimus-eluting stent)

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED